BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36908851)

  • 1. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p.
    Sulidankazha C; Alidake ; Lin H; He T; Han W; Chen Q
    Genet Res (Camb); 2023; 2023():6785005. PubMed ID: 36908851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
    Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
    Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA FOXD2-AS1 Promotes Pancreas Adenocarcinoma Cell Invasion and Migration by Sponging miR-30a-3p to Upregulate COX-2.
    Ye Z; Yang Y; Wei Y; Li L; Wang X; Zhang J
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):25-33. PubMed ID: 35377978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2.
    Fang L; Wang SH; Cui YG; Huang L
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1861-1868. PubMed ID: 33660796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1.
    Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.
    Su J; Chen D; Ruan Y; Tian Y; Lv K; Zhou X; Ying D; Lu Y
    Bioengineered; 2022 Mar; 13(3):6978-6995. PubMed ID: 35311623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
    Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis.
    Liu W; Lin W; Yu L
    Bioengineered; 2022 Jan; 13(1):1424-1435. PubMed ID: 34978261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis.
    Wang B; Sun X; Huang KJ; Zhou LS; Qiu ZJ
    World J Gastroenterol; 2021 May; 27(17):1993-2014. PubMed ID: 34007135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A; Wang J
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.
    Du J; Xiao J; Zhuo Y; Nie M; Yang J; Luo X; Gu H
    Anticancer Drugs; 2022 Sep; 33(8):720-730. PubMed ID: 35946509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.